Thrombocytopenia after Ad.26.COV2.S COVID-19 vaccine: Reports to the vaccine adverse event reporting system

Woo, EJ; Dimova, RB

Woo, EJ (通讯作者)，US FDA, Off Biostat & Pharmacovigilance, Ctr Biol Evaluat & Res, 10903 New Hampshire Ave, Silver Spring, MD 20903 USA.

VACCINE, 2022; 40 (31): 4116

Abstract

Background: On February 27, 2021, the Food and Drug Administration (FDA) issued an Emergency Use Authorization for Ad.26.COV2.S COVID-19 vaccine. As p......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索